The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...

In COPD, treatment with NAC has been shown to reduce the worsening of the condition. Bronchiectasis is a lung condition in ...

Through a 67-item online survey made by the European Multicentre Bronchiectasis Audit and Research Collaboration and the European Lung Foundation, Spinou and colleagues analyzed responses from 760 ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

interstitial lung disease, bronchiectasis, benign and malignant neoplasms, and lung transplantation. The Lung Institute has developed a comprehensive program across specialties with one site for ...

Surgery is essential for the effective management of bronchiectasis. Segmentectomy, while a challenging procedure, has become ...

One of the most striking claims in the review is that AI-based classification models can meet or exceed the performance of ...

It is estimated that some 300,000 people in the UK have bronchiectasis, a devastating chronic lung condition that causes excess mucus to build up in the lungs, resulting in frequent coughing and ...